Published September 30, 2022 | Version v1.0
Project deliverable Open

Deliverable 5.1 - Questionnaire on industrial and clinical key players and needs

  • 1. University of Latvia
  • 2. Katholieke Universiteit Leuven
  • 3. Paul Scherrer Institut
  • 4. CERN

Description

This document is a summary of responses received from the public known European industrial manufacturing and research institution and clinical facility representatives. The responses were given to the PRISMAP Consortium questionnaire disseminated in January-August 2022, approaching radionuclides and radiopharmaceutical manufacturers, research institutions and clinical end users in nuclear medicine, with the aim to identify potential stakeholders in the industrial and clinical communities interested by a coordinated approach in Europe such as PRISMAP.

The summary from PRISMAP questionnaire stratifies the feedback from 114 respondents: radionuclide and radiopharmaceutical producers, research facilities and preclinical/clinical end users. In addition, it gives an insight into the location and capabilities of the main isotope-producing cyclotron facilities, many of which are known from the IAEA cyclotron database [2]). The questionnaire was offered with an opportunity to make new research and international collaboration partners, where all parties could benefit from harmonised supply and legislation procedures, expanding network and distribution routes, and subsequently gain visibility within the PRISMAP User Forum map at www.prismap.eu. The questionnaire was focused on the radionuclide use in medicine with emphasis on future needs for specific radionuclides and possible research developments with awareness of legislation, logistics and involved personnel education challenges and future perspectives.

Files

PRISMAP_D5.1_v1.0.pdf

Files (7.5 MB)

Name Size Download all
md5:63793b3627e4bfc7c4adb93743825154
7.5 MB Preview Download

Additional details

Funding

PRISMAP – The European medical isotope programme: Production of high purity isotopes by mass separation 101008571
European Commission